US FDA’s “added sugar label” could prevent 1 million cases of cardiometabolic disease

The US Food and Drug Administration’s (FDA) impending mandatory added sugar labeling policy for packaged foods and beverages – set to take effect between 2020 and 2021 – could prevent or postpone nearly 1 million cases of cardiometabolic disease, including heart disease, stroke and Type 2 diabetes, over a 20 year period. 

En savoir plus

Les commentaires sont fermés.